Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey integrates cancer treatment with laboratory, clinical, and population research. It is part of Rutgers University and serves as the university’s principal academic cancer center, with its primary facilities in New Brunswick. The center is designated by the National Cancer Institute as a Comprehensive Cancer Center, a status reflecting activity across research, patient care, education, and community engagement.¹²

The institute’s clinical and academic work is closely connected to Rutgers Robert Wood Johnson Medical School and to RWJBarnabas Health. That structure links cancer specialists, physicians in training, scientists, hospitals, and public-health programs. Its role therefore extends beyond a single hospital: patients may encounter the institute through specialty clinics, affiliated hospitals, research programs, or regional outreach services.³

Clinical care at Rutgers Cancer Institute covers diagnosis, treatment, supportive services, and survivorship for adults and children with cancer. Multidisciplinary teams bring together medical, surgical, and radiation oncologists, pathologists, radiologists, nurses, pharmacists, social workers, and other specialists to coordinate care around a patient’s disease and circumstances.

Services include treatment for common cancers as well as specialized programs for less frequent and complex conditions. The institute also provides access to clinical trials, including studies of new drugs, combinations, procedures, and supportive approaches. Trial availability depends on eligibility, disease characteristics, prior treatment, and the study’s enrollment status; participation is voluntary and requires an informed-consent process.¹⁴

Through its partnership with RWJBarnabas Health, the institute supports cancer services across a broader New Jersey hospital network. This arrangement can connect regional patients with subspecialists and academic programs while allowing routine elements of care to remain closer to home.

Research at the institute spans basic biology, translational science, clinical investigation, and population health. Investigators study how cancers begin and spread, how tumors respond or resist treatment, and how prevention, screening, and supportive care can improve outcomes. Research programs commonly draw on genomics, immunology, drug development, imaging, and precision medicine to connect biological findings with individualized treatment decisions.¹²

As a university-based center, it also functions as a training environment for medical students, residents, fellows, graduate students, nurses, and laboratory scientists. Education is tied to patient care and research rather than separated from them: clinical observations can generate research questions, while discoveries can move toward trials and practice. Community programs address cancer prevention, screening, health literacy, and cancer disparities, with particular attention to populations whose access or outcomes differ across New Jersey.¹³

The institute’s comprehensive designation reflects more than the presence of oncology clinics; it recognizes an interconnected institutional program that includes research infrastructure, workforce training, outreach, and quality-focused care. This distinction helps explain why the center may be involved in a patient’s care even when the immediate treatment occurs at an affiliated location rather than in a research laboratory or at the New Brunswick campus.²

Its less visible work includes biobanking and the careful handling of research specimens, registry and population studies, prevention initiatives, and survivorship services. These activities produce evidence about cancer risk, treatment effects, late complications, and unequal outcomes that cannot be answered by one patient visit alone. The partnership model also creates a practical bridge between a nationally recognized academic center and community hospitals throughout the state, an arrangement intended to broaden access to specialized expertise and research opportunities.¹

Rutgers Cancer Institute operates within the public research-university environment of Rutgers while collaborating clinically with RWJBarnabas Health. Its public role includes advancing cancer science, educating health professionals, delivering specialized care, and translating research into services that can benefit residents across New Jersey.³

The institute’s NCI designation places it within a national network of centers evaluated for scientific leadership and broad cancer-control activities. That status does not mean every treatment is experimental or that every patient is enrolled in research; most care remains standard clinical treatment, while research participation is offered when an appropriate study exists.²⁴

Comprehensive Cancer Center

A National Cancer Institute designation for centers demonstrating substantial strength across cancer research, treatment, education, and outreach.

Clinical trial

A planned study involving human participants that evaluates a medical intervention, diagnostic approach, or supportive-care strategy.

Precision medicine

An approach that uses characteristics of a patient or tumor, such as molecular alterations, to help guide prevention or treatment.

Survivorship

The continuing medical, psychological, and practical care of people living during or after cancer treatment.